Making top-quality cancer care accessible to all.100% free, no account required.

Looking at How Blood and Tissue Samples Help Understand Cancer

NCT00026884 · Recruiting
About this trial

This trial is looking at how collecting blood and tissue samples can help researchers understand cancers such as kidney, bladder, and prostate cancer. It aims to find out more about the genes that cause these types of cancer. By studying these samples, scientists hope to improve future treatments and understand how to better care for patients with these conditions.

Locations and contact

This trial is running at 1 location in the United States. It is currently recruiting.

United States1 location · 1 recruiting
  • National Institutes of Health Clinical CenterBethesda, MarylandRecruiting
Who to ask about joining
W. Marston Linehan, M.D.(240) 858-3700linehanm@mail.nih.gov
Who can join

Anyone aged 2 years or older can join, including men and women. You can participate if you have been diagnosed with cancer or if you are suspected of having cancer. Family members of people with certain inherited cancers can also join. The trial team will check to make sure everyone meets the eligibility requirements.

What happens during the trial

Participants will visit the Urologic Oncology Branch for screening. Blood and urine samples may be collected. If participants have surgery, both normal and cancerous tissues may be taken during the procedure. The trial includes family members of those with cancer or inherited cancer risks. Everyone's samples will be used for research to improve understanding of cancer.

The trial team

The trial is sponsored by the National Cancer Institute (NCI). Dr. W. Marston Linehan leads the study at NCI. They work to understand urologic cancers better.

Important dates

This trial started on March 12, 1998, and is still recruiting new participants. It is expected to continue until June 16, 2026.

Additional information

The trial ID is NCT00026884. It is an observational study, which means it is looking at how things are without changing any treatments. The study is not about a specific drug or device approved by the FDA. About 5,950 participants are expected to take part.

Similar trials

Other recruiting trials for the same condition, with the eligibility rules written in plain language.

Browse similar trials
Talk to a specialist

Find a top oncologist who can tell you whether a trial is a sensible option for you.

Find a doctor
Cancer hospitals

The cancer centers running studies like this one, and what each is known for.

Browse hospitals